The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ACADIA PHARMACEUTICALS INC | COM | 004225108 | 8,834 | 206,500 | SH | SOLE | 206,500 | 0 | 0 | ||
ACHILLION PHARMACEUTICALS INC | COM | 00448Q201 | 4,583 | 760,000 | SH | SOLE | 760,000 | 0 | 0 | ||
AMARIN CORP PLC | SPONSORED ADR | 023111206 | 14,258 | 665,000 | SH | SOLE | 665,000 | 0 | 0 | ||
APTOSE BIOSCIENCES INC | COM NEW | 03835T200 | 23,162 | 4,085,000 | SH | SOLE | 4,085,000 | 0 | 0 | ||
AQUESTIVE THERAPEUTICS INC | COM | 03843E104 | 4,298 | 738,500 | SH | SOLE | 738,500 | 0 | 0 | ||
AUDENTES THERAPEUTICS INC | COM | 05070R104 | 17,473 | 292,000 | SH | SOLE | 292,000 | 0 | 0 | ||
AVENUE THERAPEUTICS INC | COM NEW | 05360L205 | 9,936 | 1,035,000 | SH | SOLE | 1,035,000 | 0 | 0 | ||
AXOGEN INC | COM | 05463X106 | 12,523 | 700,000 | SH | SOLE | 700,000 | 0 | 0 | ||
BIOHAVEN PHARMACEUTICAL HLDG | COM | G11196105 | 8,983 | 165,000 | SH | SOLE | 165,000 | 0 | 0 | ||
BIOLINERX LTD | SPONSORED ADR | 09071M106 | 38 | 16,667 | SH | SOLE | 16,667 | 0 | 0 | ||
BLUEPRINT MEDICINES CORP | COM | 09627Y109 | 8,001 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
CERECOR INC | COM | 15671L109 | 11,808 | 2,190,674 | SH | SOLE | 2,190,674 | 0 | 0 | ||
CHEMOCENTRYX INC | COM | 16383L106 | 13,846 | 361,600 | SH | SOLE | 361,600 | 0 | 0 | ||
CODEXIS INC | COM | 192005106 | 22,286 | 1,400,000 | SH | SOLE | 1,400,000 | 0 | 0 | ||
CRINETICS PHARMACEUTICALS INC | COM | 22663K107 | 6,676 | 266,100 | SH | SOLE | 266,100 | 0 | 0 | ||
DECIPHERA PHARMACEUTICALS IN | COM | 24344T101 | 13,973 | 224,500 | SH | SOLE | 224,500 | 0 | 0 | ||
EDAP TMS SA | SPONSORED ADR | 268311107 | 7,908 | 1,785,000 | SH | SOLE | 1,785,000 | 0 | 0 | ||
EIDOS THERAPEUTICS INC | COM | 28249H104 | 18,109 | 315,550 | SH | SOLE | 315,550 | 0 | 0 | ||
EPIZYME INC | COM | 29428V104 | 34,051 | 1,384,200 | SH | SOLE | 1,384,200 | 0 | 0 | ||
ETON PHARMACEUTICALS INC | COM | 29772L108 | 10,580 | 1,469,456 | SH | SOLE | 1,469,456 | 0 | 0 | ||
FENNEC PHARMACEUTICALS INC | COM | 31447P100 | 78 | 12,000 | SH | SOLE | 12,000 | 0 | 0 | ||
FIBROGEN INC | COM | 31572Q808 | 6,262 | 146,000 | SH | SOLE | 146,000 | 0 | 0 | ||
FLEXION THERAPEUTICS INC | COM | 33938J106 | 8,601 | 415,500 | SH | SOLE | 415,500 | 0 | 0 | ||
FORTRESS BIOTECH INC | COM | 034960Q19 | 9,831 | 3,825,100 | SH | SOLE | 3,825,100 | 0 | 0 | ||
FORTY SEVEN INC | COM | 34983P104 | 22,126 | 562,000 | SH | SOLE | 562,000 | 0 | 0 | ||
HARROW HEALTH | COM | 45323A201 | 18,205 | 2,340,000 | SH | SOLE | 2,340,000 | 0 | 0 | ||
INTRA CELLULAR THERAPIES INC | COM | 46116X101 | 13,950 | 406,600 | SH | SOLE | 406,600 | 0 | 0 | ||
KADMON HOLDINGS INC | COM | 48283N106 | 4,260 | 940,373 | SH | SOLE | 940,373 | 0 | 0 | ||
MACROGENICS INC | COM | 556099109 | 2,181 | 200,500 | SH | SOLE | 200,500 | 0 | 0 | ||
MAGENTA THERAPEUTICS INC | COM | 55910K108 | 6,728 | 449,950 | SH | SOLE | 449,950 | 0 | 0 | ||
NEOLEUKIN THERAPEUTICS INC | COM | 64049K104 | 17,018 | 1,381,300 | SH | SOLE | 1,381,300 | 0 | 0 | ||
OCULAR THERAPEUTIX INC | COM | 67576A100 | 20,175 | 5,107,500 | SH | SOLE | 5,107,500 | 0 | 0 | ||
ODONATE THERAPEUTICS INC | COM | 676079106 | 11,520 | 355,000 | SH | SOLE | 355,000 | 0 | 0 | ||
PROTEON THERAPEUTICS INC | COM | 74371L109 | 75 | 188,144 | SH | SOLE | 188,144 | 0 | 0 | ||
PTC THERAPEUTICS INC | COM | 69366J200 | 9,174 | 191,000 | SH | SOLE | 191,000 | 0 | 0 | ||
QUANTERIX CORP | COM | 74766Q101 | 3,124 | 132,200 | SH | SOLE | 132,200 | 0 | 0 | ||
RA PHARMACEUTICALS INC | COM | 74933V108 | 6,655 | 141,800 | SH | SOLE | 141,800 | 0 | 0 | ||
RADIUS HEALTH INC | COM NEW | 750469207 | 3,387 | 168,000 | SH | SOLE | 168,000 | 0 | 0 | ||
RHYTHM PHARMACEUTICALS INC | COM | 76243J105 | 2,537 | 110,500 | SH | SOLE | 110,500 | 0 | 0 | ||
STEREOTAXIS INC | COM NEW | 85916J409 | 22,025 | 4,112,500 | SH | SOLE | 4,112,500 | 0 | 0 | ||
TELA BIO INC | COM | 872381108 | 2,266 | 175,000 | SH | SOLE | 175,000 | 0 | 0 | ||
TG THERAPEUTICS INC | COM | 88322Q108 | 6,434 | 579,651 | SH | SOLE | 579,651 | 0 | 0 | ||
TRICIDA INC | COM | 89610F101 | 7,303 | 194,000 | SH | SOLE | 194,000 | 0 | 0 | ||
TURNING POINT THERAPEUTICS INC | COM | 90041T108 | 21,210 | 340,500 | SH | SOLE | 340,500 | 0 | 0 | ||
UNIQURE NV | SHS | N90064101 | 15,049 | 210,000 | SH | SOLE | 210,000 | 0 | 0 | ||
XOMA CORP DEL | COM NEW | 98419J206 | 10,195 | 373,450 | SH | SOLE | 373,450 | 0 | 0 | ||
ZYMEWORKS INC | COM | 98985W102 | 7,956 | 175,000 | SH | SOLE | 175,000 | 0 | 0 |